Medicines Used to Treat Post-Traumatic Stress Disorder (PTSD)

Authors

  • Hamza Khalifa Ibrahim Department of Pharmaceutical Technology, Higher Institute of Medical Sciences and Technologies, Bani Walid, Libya
  • Maab Jumaa Ghumid Department of Pharmaceutical Technology, Higher Institute of Medical Sciences and Technologies, Bani Walid, Libya
  • Om Kulthum Shaaban AL-Sadiq Department of Pharmaceutical Technology, Higher Institute of Medical Sciences and Technologies, Bani Walid, Libya

Keywords:

PTSD, Trauma, Psychotherapy, Ketamine, MDMA-assisted Psychotherapy, Pharmacogenomics, Personalized Treatment, Emerging Treatments.

Abstract

Post-traumatic stress disorder (PTSD) remains a significant challenge for many individuals worldwide, often following exposure to traumatic events. This paper explores the aftermath of trauma, emphasizing the importance of psychotherapy and the role of medications in treating PTSD. We delve into the controversy surrounding benzodiazepines, while highlighting emerging treatments and future directions. Personal anecdotes illustrate the profound impact of these treatments on individuals' lives, offering hope for recovery. The ongoing advancements in pharmacogenomics and novel therapeutic approaches promise to personalize and improve PTSD care, paving the way for more effective and sustainable treatment options.

Published

2024-08-09

How to Cite

Hamza Khalifa Ibrahim, Maab Jumaa Ghumid, & Om Kulthum Shaaban AL-Sadiq. (2024). Medicines Used to Treat Post-Traumatic Stress Disorder (PTSD). Libyan Journal of Medical and Applied Sciences, 2(1), 11–19. Retrieved from https://ljmas.com/index.php/journal/article/view/19

Issue

Volume 2, Issue 2, 2024

Section

Life Sciences
Copyright & Licensing
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.